
1. lancet. 2005 jun 11-17;365(9476):2041-54.

nasopharyngeal carcinoma.

wei wi(1), sham js.

author information: 
(1)department surgery, university hong kong medical centre, queen mary
hospital, hong kong sar, china. hrmswwi@hkucc.hku.hk

incidence nasopharyngeal carcinoma remained high endemic regions.
diagnosing disease early stages requires high index clinical
acumen and, although cross-sectional imaging investigations show tumour 
with precision, confirmation dependent histology. epstein-barr virus
(ebv)-encoded rna signal present nasopharyngeal carcinoma cells, and
early diagnosis disease possible detection raised
antibodies ebv. quantity ebv dna detected blood indicates the
stage prognosis disease. radiotherapy concomitant chemotherapy
has increased survival, improved techniques (such intensity-modulated
radiotherapy), early detection recurrence, application appropriate
surgical salvage procedures contributed improved therapeutic results.
screening high-risk individuals endemic regions together developments 
in gene therapy immunotherapy might improve outcome.

doi: 10.1016/s0140-6736(05)66698-6 
pmid: 15950718  [indexed medline]

